Sylentis
Manufacturing · Spain · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 C/ Santiago Grisolía, Madrid, Madrid, ...Phone Number
+34 918047667Website
www.sylentis.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Sylentis
Sylentis is a biopharmaceutical company specializing in RNA interference (RNAi) technology aimed at improving eye health. Their innovative products, including Tivanisiran for dry eye syndrome and SYL1801 for age-related macular degeneration, are designed to target and silence specific genes responsible for ocular diseases. The company also offers custom development services for siRNA compounds, leveraging their proprietary SirFinder software to enhance drug design. Sylentis collaborates with pharmaceutical and biopharmaceutical companies to advance next-generation therapies in the ophthalmological field.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sylentis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sylentis has new funding data
Earning: See what the market has to say on Sylentis recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sylentis
Check if Sylentis has recently received funding, and reach out quickly before it becomes old news!
Click to see if Sylentis had a recent Job posting/layoffs
Product Launch: Get notified when Sylentis launches new products
Sylentis, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Sylentis is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Sylentis as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Sylentis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sylentis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sylentis.
Sylentis Tech Stack
A closer look at the technologies used by Sylentis
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Project
Clinical Systems
Sylentis News & Media
Sylentis Announces New Data on the Treatment of Allergic Conjunctivitis
MADRID, May 7, 2018 /PRNewswire/ -- • The results of SYL116011 have demonstrated that this treatment reduces the symptoms related to the allergy in 50% to 80%[i] . • The ARVO meeting has considered the poster presentation to be of scientific interest, contributing therefore...Sylentis Presented New Results for the Treatment of Age Associated Macular Degeneration
MADRID, May 4, 2018 /PRNewswire/ -- Within the framework of the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), that has been held from the 29th of April to the 3rd of May in Honolulu (Hawaii), Sylentis, pharmaceutical company belonging to the PharmaMar...Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome
MADRID, May 3, 2018 /PRNewswire/ -- The studies carried out with tivanisiran showed an improvement in the inflammatory ocular parameters, tear quality, and a reduction in ocular pain, that is associated with dry eye syndrome[i] Sylentis, Pharmaceutical Company belonging...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sylentis
Sign Up For FreeTo access detailed company insights
Sylentis is a biopharmaceutical company specializing in RNA interference (RNAi) technology aimed at improving eye health. Their innovative products, including Tivanisiran for dry eye syndrome and SYL1801 for age-related macular degeneration, are designed to target and silence specific genes responsible for ocular diseases. The company also offers c... Read More
